4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow tecogalan: new trials by email Literature Review of tecogalan trials Research Report on tecogalan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days Tecogalan sodium - Sarcoma, Kaposi, HIV Infections | Phase 1 | Completed | Daiichi Pharmaceuticals | 2005-06-24 | ||
| A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 Tecogalan sodium - Sarcoma, Kaposi, HIV Infections | Phase 1 | Completed | Daiichi Pharmaceuticals | 2005-06-24 | ||
| A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. Tecogalan sodium - Sarcoma, Kaposi, HIV Infections | Phase 1 | Completed | Daiichi Pharmaceuticals | 2005-06-24 | ||
| A Study of Tecogalan Sodium Tecogalan sodium - Sarcoma, Kaposi, HIV Infections | Phase 1 | Completed | Daiichi Pharmaceuticals | 2005-06-24 |
Acquired Immunodeficiency Syndrome (4) · HIV Infections (4) · Neoplasms (4) · Sarcoma, Kaposi (4)
United States (4)